alli, a trade mark of GlaxoSmithKline, is planning to launch new chewable tablets for overweight adults, which are to be on sale in pharmacies in the UK in April 2011.
125376
Alli to launch new chewable tablets for overweight adults
4646
Lipitor to be available in generic form
3143
'Companies to focus more on health initiatives'
66069
Targacept publicly offering 2.2 million shares
105503
GlaxoSmithKline forfeits millions in incentives
42416
Allcare close to entering agreements with dentists
118459
GlaxoSmithKline to create up to 1,000 jobs
143760
GlaxoSmithKline to cut 130 jobs (gsk)
33893
Atkins set to launch reformulated snack bars
95911
Sanofi-Aventis to acquire Genzyme?
84475
Glaxosmithkline (GSK) has been looking into claims from an anonymous tipster that its Chinese
7541
Xyratex expands product portfolio
79889
Merck buys drug rival Schering-Plough
169887
Aventis Pharma launches disposable insulin pen
72621
OncoGenex Pharmaceuticals files shelf registration statement
73994
GlaxoSmithKline uses clinical graphics solution developed by Insightful Corporation
147065
Glaxosmithkline not to pursue further worldwide development of Simplirix